INGN: Inogen, Inc. Short-Term Debt to Equity

Symbol and logo of brand Inogen Medical (INGN)

Inogen, Inc. (INGN) ensures the stability of its global supplies through a network of plants in Europe and Texas. Despite the stagnation of current technologies, steady demand for equipment supports a cash flow that is currently 0.02. This trading chart complements the analysis of a business that created ultralight devices for the mobility of lung patients, eliminating the need for bulky tanks.

Inogen, Inc. - INGN Short-Term Debt to Equity Ratio (period 07/04/2022 - 10/28/2026)
Signature product of Inogen, Inc.

This metric calculates the proportion of short-term liabilities relative to the company's equity. This ratio determines the financial stability and the ability of the company to settle debts due within one year without seeking new financing. For Inogen, Inc. (INGN), stable demand for oxygen therapy creates a predictable cash flow, mitigating liquidity risks. The current trend of the short-term debt-to-equity ratio reflects the balance between aggressive growth and solvency.